These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
95 related articles for article (PubMed ID: 14021803)
1. Electron-microscopic changes produced in the human endometrium by norethindrone acetate with ethinyl estradiol. CLYMAN MJ Fertil Steril; 1963; 14():352-64. PubMed ID: 14021803 [No Abstract] [Full Text] [Related]
2. A randomized, double-blind, placebo-controlled, multicenter study that assessed the endometrial effects of norethindrone acetate plus ethinyl estradiol versus ethinyl estradiol alone. Portman DJ; Symons JP; Wilborn W; Kempfert NJ Am J Obstet Gynecol; 2003 Feb; 188(2):334-42. PubMed ID: 12592236 [TBL] [Abstract][Full Text] [Related]
3. Contrasting effects of two hormone replacement therapies on the cardiovascular and mammary gland outcomes in surgically postmenopausal monkeys. Suparto IH; Williams JK; Cline JM; Anthony MS; Fox JL Am J Obstet Gynecol; 2003 May; 188(5):1132-40. PubMed ID: 12748457 [TBL] [Abstract][Full Text] [Related]
4. A study of combined continuous ethinyl estradiol and norethindrone acetate for postmenopausal hormone replacement. Williams SR; Frenchek B; Speroff T; Speroff L Am J Obstet Gynecol; 1990 Feb; 162(2):438-46. PubMed ID: 2309827 [TBL] [Abstract][Full Text] [Related]
5. THE EFFECT OF NORETHINDRONE ACETATE-ETHINYL ESTRADIOL, CLOMIPHENE CITRATE, AND DYDROGESTERONE ON SPINNBARKEIT. COHEN MR; PEREZ-PELAEZ M Fertil Steril; 1965; 16():141-50. PubMed ID: 14261217 [No Abstract] [Full Text] [Related]
6. Insulin sensitivity is decreased in normal women by doses of ethinyl estradiol used in oral contraceptives. Kojima T; Lindheim SR; Duffy DM; Vijod MA; Stanczyk FZ; Lobo RA Am J Obstet Gynecol; 1993 Dec; 169(6):1540-4. PubMed ID: 8267059 [TBL] [Abstract][Full Text] [Related]
7. CLINICAL EVALUATION OF NORETHINDRONE ACETATE IN FERTILITY CONTROL. RICE WRAY E; GONZALEZ O; FERRER S; ARANDA ROSELL A; MAQUEO M; MUNGUIA H Am J Obstet Gynecol; 1965 Sep; 93():115-21. PubMed ID: 14329159 [No Abstract] [Full Text] [Related]
8. Control of fertility with oral medication. Diddle AW; Watts GF; Gardner WH; Williamson PJ West J Surg Obstet Gynecol; 1964; 72():222-9. PubMed ID: 12305556 [TBL] [Abstract][Full Text] [Related]
9. Reduced vaginal bleeding in postmenopausal women who receive combined norethindrone acetate and low-dose ethinyl estradiol therapy versus combined conjugated equine estrogens and medroxyprogesterone acetate therapy. Simon JA; Liu JH; Speroff L; Shumel BS; Symons JP Am J Obstet Gynecol; 2003 Jan; 188(1):92-9. PubMed ID: 12548201 [TBL] [Abstract][Full Text] [Related]
10. Gabapentin does not interact with a contraceptive regimen of norethindrone acetate and ethinyl estradiol. Eldon MA; Underwood BA; Randinitis EJ; Sedman AJ Neurology; 1998 Apr; 50(4):1146-8. PubMed ID: 9566412 [TBL] [Abstract][Full Text] [Related]
11. Changes in coagulation and anticoagulation in women taking low-dose triphasic oral contraceptives: a controlled comparative 12-month clinical trial. Notelovitz M; Kitchens CS; Khan FY Am J Obstet Gynecol; 1992 Nov; 167(5):1255-61. PubMed ID: 1442974 [TBL] [Abstract][Full Text] [Related]
12. Combined continuous ethinyl estradiol/norethindrone acetate does not improve forearm blood flow in postmenopausal women at risk for cardiovascular events: a pilot study. Duvernoy CS; Rose PA; Kim HM; Kehrer C; Brook RD J Womens Health (Larchmt); 2007 Sep; 16(7):963-70. PubMed ID: 17903073 [TBL] [Abstract][Full Text] [Related]
13. Norethindrone acetate (NA) and ethinyl estradiol (EE) related oxidative transformation products in stability samples of formulated drug product: synthesis of authentic references. Ekhato IV; Hurley T; Lovdahl M; Revitte TJ; Guo L; Huang Y; Clipper S; Colson C Steroids; 2002 Mar; 67(3-4):165-74. PubMed ID: 11856540 [TBL] [Abstract][Full Text] [Related]
14. Use of Anovlar in gynaecological disorders and contraception. Shahani SM; Chiklikar A J Obstet Gynaecol India; 1968 Apr; 18(2):592-7. PubMed ID: 12331827 [TBL] [Abstract][Full Text] [Related]
15. Mutual modification of glucose-stimulated serum insulin responses in female rhesus monkeys by ethinyl estradiol and nortestosterone derivatives. Beck P; Venable RL; Hoff DL J Clin Endocrinol Metab; 1975 Jul; 41(1):44-53. PubMed ID: 50326 [TBL] [Abstract][Full Text] [Related]
16. Follicular development in a 7-day versus 4-day hormone-free interval with an oral contraceptive containing 20 mcg ethinyl estradiol and 1 mg norethindrone acetate. Rible RD; Taylor D; Wilson ML; Stanczyk FZ; Mishell DR Contraception; 2009 Mar; 79(3):182-8. PubMed ID: 19185670 [TBL] [Abstract][Full Text] [Related]
17. Thalidomide does not alter the pharmacokinetics of ethinyl estradiol and norethindrone. Trapnell CB; Donahue SR; Collins JM; Flockhart DA; Thacker D; Abernethy DR Clin Pharmacol Ther; 1998 Dec; 64(6):597-602. PubMed ID: 9871424 [TBL] [Abstract][Full Text] [Related]
18. THE INHIBITION OF OVULATION WITH ORAL PROGESTATIVE SUBSTANCES. KAISER R Int J Fertil; 1964; 9():87-93. PubMed ID: 14106272 [No Abstract] [Full Text] [Related]
19. Single- and multiple-dose pharmacokinetics of a low-dose oral contraceptive in women with chronic renal failure undergoing peritoneal dialysis. Price TM; Dupuis RE; Carr BR; Stanczyk FZ; Lobo RA; Droegemueller W Am J Obstet Gynecol; 1993 May; 168(5):1400-6. PubMed ID: 8498419 [TBL] [Abstract][Full Text] [Related]
20. EFFECTS OF PROLONGED ADMINISTRATION OF PROGESTINS ON THE ENDOMETRIUM AND THE FUNCTION OF THE PITUITARY, THYROID AND ADRENAL GLANDS. WALSER HC; MARGULIS RR; LADD JE Int J Fertil; 1964; 9():189-95. PubMed ID: 14106256 [No Abstract] [Full Text] [Related] [Next] [New Search]